NEOPLASMS, HEAD AND NECK

Clinical trials for NEOPLASMS, HEAD AND NECK explained in plain language.

Never miss a new study

Get alerted when new NEOPLASMS, HEAD AND NECK trials appear

Sign up with your email to follow new studies for NEOPLASMS, HEAD AND NECK, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 2 Completed 2

New hope to keep aggressive head & neck cancer at bay

Disease control Recruiting now

This study is for adults with a specific type of advanced head and neck cancer who have just finished standard chemoradiation treatment. The goal is to see if adding a drug called dostarlimab (an immunotherapy) after that standard treatment is better than a placebo at keeping the…

Matched conditions: NEOPLASMS, HEAD AND NECK

Phase: PHASE3 • Sponsor: GlaxoSmithKline • Aim: Disease control

Last updated Mar 16, 2026 15:23 UTC

NEOPLASMS, HEAD AND NECK

Get alerted when new NEOPLASMS, HEAD AND NECK trials appear

New hope to keep aggressive head & neck cancer at bay